|
|
|
| Comparison of Biomarkers in Asthma COPD and Asthma-COPD Overlap |
| Yao Zhihui, Liu Xingdong*, Xie Junying |
| Department of Respiratory and Critical Care Medicine,First People's Hospital of Hengyang City,Hunan 421002 |
|
|
|
|
Abstract Objective To compare biomarkers in asthma,COPD,and asthma-COPD overlap(ACO). Methods 50 patients per group(asthma,COPD,ACO,and healthy controls)were included.Inflammatory,protease-related,and fibrotic biomarkers were analyzed.Correlation analysis assessed biomarker-disease associations. Results Eosinophilic markers(FeNO, IL-5)were highest in asthma,neutrophil/protease markers(MMP-9, NE)in COPD,and TGF-β in ACO.FeNO correlated strongly with asthma,MMP-9 with COPD,and TGF-β most strongly with ACO. Conclusion Asthma shows eosinophilic inflammation,COPD exhibits neutrophilic inflammation and oxidative stress,while ACO combines features of both with a distinct pro-fibrotic profile.
|
|
Received: 15 February 2026
|
|
|
|
|
|
[1] 平措卓玛,嘎玛仓决,卓嘎次西,等.2020年西藏自治区居民慢性阻塞性肺疾病知识知晓率及其影响因素分析[J].中国健康教育,2025,41(8):697-701. [2] 杨韵滢,吴静溢,赵海方.基于证素辨证学探讨哮喘-慢阻肺重叠的中医证素分布特点及其影响因素的相关性研究[J].广州中医药大学学报,2025,42(10):2380-2386. [3] 陈海杰,周雨缪,张静,等.哮喘-慢性阻塞性肺疾病重叠生物标志物研究进展[J].中华健康管理学杂志,2023,17(5):395-400. [4] 朱亚军,包拯,徐志,等.泛免疫炎症值联合多因素预测模型对慢阻肺风险的预测价值:基于2013-2023年NHANES数据的横断面研究[J].临床肺科杂志,2025,30(9):1404-1412. [5] 祝小燕,张俊,谭传伟.哮喘-慢性阻塞性肺疾病重叠与慢性阻塞性肺疾病患者下呼吸道感染病原学、气道重塑特征分析[J].实用医院临床杂志,2025,22(2):167-171. [6] 陈锐佳,吴少燕,陈锐凯.外周血嗜酸性粒细胞联合FeNO检测在哮喘-慢阻肺重叠综合征表型分类中的应用价值[J].当代医药论丛,2025,23(33):94-97. [7] 杨晓竹,戴宁,江美芳.老年慢阻肺稳定期患者肺泡灌洗液细胞因子、组织蛋白酶S水平与肺功能的关系及预测急性加重的效能分析[J].老年医学与保健,2025,31(1):152-156. [8] 邱泊霖,洪露娜,黄林洁,等.嗜酸性粒细胞过氧化物酶放大IL-4诱导的巨噬细胞M2极化促进哮喘气道炎症[J].岭南急诊医学杂志,2025,30(2):133-137,162. [9] 师丽敏,刘红红,崔波.支气管哮喘患者TGF-β/Smad信号传导通路表达与病情严重程度的关系[J].临床和实验医学杂志,2025,24(17):1801-1804. |
| [1] |
. [J]. journal1, 2026, 46(4): 48-51. |
| [2] |
. [J]. journal1, 2026, 46(4): 133-135. |
| [3] |
. [J]. journal1, 2026, 46(2): 103-106. |
| [4] |
Yang Zhilu, Sha ZhengKai, Zhang Xiangjie, Zhang Pan, Liu Xiaoxiao. Analysis of Risk Factors for Lung Cancer in Chronic Obstructive Pulmonary Disease with Emphysema Type[J]. journal1, 2026, 46(1): 8-12. |
| [5] |
. [J]. journal1, 2025, 45(5): 104-106. |
| [6] |
. [J]. journal1, 2025, 45(2): 75-77. |
|
|
|
|